tirzepatide dvt Acute Deep Vein Thrombosis in the Setting of Use: A Case Highlighting Emerging Concerns Novel finding of pulmonary embolism
Description
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with glucagon-like peptide-1 agonist (GLP-1a), including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide)
JPML has created a new multidistrict litigation for lawsuits alleging that GLP-1 receptor agonist drugs cause NAION, a serious vision injury.
Bundle Features
Combining glutathione with tirzepatide is an emerging approach some practitioners explore, but clinical evidence remains limited
We will continue to monitor the phenomenal up-take of GLP-1 drugs (recognizing its growing pipeline shown in the chart above) and patients perspectives of the use of these medications both those people prescribed them to treat medical obesity and those consumers willing to pay for them out-of-pocket
Safe, effective care administered by experienced professionals.
